Literature DB >> 31953719

The role of hypertriglyceridemia and treatment patterns in the progression of IgA nephropathy with a high proportion of global glomerulosclerosis.

Jiayi Wang1, Lingyan He1, Wenzhe Yan2, Xiaofei Peng3, Liyu He1, Danyi Yang1, Hong Liu4, Youming Peng1.   

Abstract

PURPOSE: Many studies have focused on finding predictors for mild IgAN progression. However, the cases of severe IgAN with a high proportion of global glomerulosclerosis have received inadequate attention.
METHODS: A group of 172 primary IgAN patients with 50-75% global glomerulosclerosis was studied retrospectively between April 2007 and October 2017. Patients were divided into three groups according to the serum triglyceride tertiles:  < 1.42 µmol/L (Group 1), 1.42-2.29 µmol/L (Group 2), and > 2.29 µmol/L (Group 3). Groups 1 and 2 comprised non-hypertriglyceridemia subjects, while Group 3 was defined as the hypertriglyceridemia (HTG) group. The patients were followed for 4-96 months (median 39.43 months). The study end point was defined as a 50% decline in estimated glomerular filtration rate (eGFR) or ESRD.
RESULTS: A high proportion of global glomerulosclerosis is not absolutely correlated with severe clinical features and poor renal outcome. In our retrospective observation, eGFR decreased by less than 10% of the baseline during follow-up in 43.6% of the patients. However, in our patients with HTG, the cumulative renal survival rate was significantly lower compared to those without HTG. Multivariate Cox regression analysis also showed that triglyceride is an independent predictor of poor renal outcomes. Furthermore, in the HTG group, the cumulative renal survival rates were higher in patients treated with Tripterygium wilfordii Hook F (TwHF) compared to those without TwHF.
CONCLUSIONS: A high proportion of global glomerulosclerosis combined with HTG at biopsy have better predictive validity for the disease progression of IgAN than global glomerulosclerosis alone. TwHF may partially affect the renal outcome of severe IgAN with HTG, and this may relate to its regulation of lipid metabolism and immunoinflammatory response.

Entities:  

Keywords:  Global glomerulosclerosis; Hypertriglyceridemia; IgA nephropathy; Renal outcome; TwHF

Mesh:

Substances:

Year:  2020        PMID: 31953719     DOI: 10.1007/s11255-019-02371-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  42 in total

1.  Combined Immunosuppressive Treatment May Improve Short-Term Renal Outcomes in Chinese Patients with Advanced IgA Nephropathy.

Authors:  Li Tan; Yi Tang; Wei Peng; Bechu Shelley Mathew; Wei Qin
Journal:  Kidney Blood Press Res       Date:  2018-08-10       Impact factor: 2.687

2.  Plasma triglycerides as a risk factor for chronic kidney disease in type 2 diabetes mellitus: Evidence from northeastern Thailand.

Authors:  Sojib Bin Zaman; Mohd Anisul Karim; Naznin Hossain; Gulam Muhammed Al Kibria; Sheikh Mohammed Shariful Islam
Journal:  Diabetes Res Clin Pract       Date:  2018-02-12       Impact factor: 5.602

Review 3.  Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors.

Authors:  G D'Amico
Journal:  Am J Kidney Dis       Date:  2000-08       Impact factor: 8.860

4.  Histopathologic features aid in predicting risk for progression of IgA nephropathy.

Authors:  Michael Walsh; Aylin Sar; Diane Lee; Serdar Yilmaz; Hallgrimur Benediktsson; Braden Manns; Brenda Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

5.  Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population.

Authors:  Takumi Yoshida; Takashi Takei; Satsuki Shirota; Misao Tsukada; Hidekazu Sugiura; Mitsuyo Itabashi; Tetsuya Ogawa; Keiko Uchida; Ken Tsuchiya; Kosaku Nitta
Journal:  Intern Med       Date:  2008-11-04       Impact factor: 1.271

6.  Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy.

Authors:  Neelamegam Kandasamy; Natarajan Ashokkumar
Journal:  Eur J Pharmacol       Date:  2014-09-18       Impact factor: 4.432

7.  Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease.

Authors:  Wenxia Yang; Ying Luo; Shikun Yang; Mengru Zeng; Shumin Zhang; Jialu Liu; Yuzhang Han; Yu Liu; Xuejing Zhu; Hao Wu; Fuyou Liu; Lin Sun; Li Xiao
Journal:  Clin Sci (Lond)       Date:  2018-11-21       Impact factor: 6.124

8.  Clinicopathological Characteristics, Role of Immunosuppressive Therapy and Progression in IgA Nephropathy with Hyperuricemia.

Authors:  Yiping Ruan; Fuyuan Hong; Jiabin Wu; Miao Lin; Chen Wang; Fayang Lian; Fang Cao; Guokai Yang; Meizhu Gao
Journal:  Kidney Blood Press Res       Date:  2018-07-17       Impact factor: 2.687

9.  Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury.

Authors:  Hazel H Szeto; Shaoyi Liu; Yi Soong; Nazia Alam; Glen T Prusky; Surya V Seshan
Journal:  Kidney Int       Date:  2016-08-09       Impact factor: 10.612

10.  Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy.

Authors:  Celine Nguyen; Katrin König; Frederick W K Tam; Helmut Hopfer; Karen Molyneux; Francoise-Isabelle Binet; Min Jeong Kim
Journal:  Clin Kidney J       Date:  2018-08-03
View more
  5 in total

1.  Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy.

Authors:  Lei Dong; Yue-Qiang Li; Shui-Ming Guo; Gang Xu; Wang Wei; Min Han
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

2.  Dyslipidemia may be a risk factor for progression in children with IgA nephropathy.

Authors:  Hongjie Zhuang; Zhilang Lin; Shuhan Zeng; Mengjie Jiang; Lizhi Chen; Xiaoyun Jiang; Yuanyuan Xu
Journal:  Pediatr Nephrol       Date:  2022-03-28       Impact factor: 3.651

3.  The predictive value of Oxford MEST-C classification to immunosuppressive therapy of IgA nephropathy.

Authors:  YuanFan Rui; ZiJun Yang; ZiHan Zhai; Cong Zhao; Lin Tang
Journal:  Int Urol Nephrol       Date:  2021-08-12       Impact factor: 2.370

4.  Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy.

Authors:  Bingman Liu; Liangyu Zhao; Qingqing Yang; Dongqing Zha; Xiaoyun Si
Journal:  Int Urol Nephrol       Date:  2021-04-24       Impact factor: 2.370

5.  Utility of non-HDL-C in predicting proteinuria remission of idiopathic membranous nephropathy: a retrospective cohort study.

Authors:  Lei Dong; Wang Wei; Min Han; Gang Xu
Journal:  Lipids Health Dis       Date:  2021-09-29       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.